United States & BeOne Medicines
3 shared events · Importance 3 · Last updated Sep 01, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Domestic
United States: The U.S. government, through the United States — White House, negotiated the drug pricing deals to lower costs for patients and reduce federal spending. The agreements are part of a broader push to make healthcare more affordable.
BeOne Medicines: BeOne Medicines agreed to provide an oncology medicine at reduced United States — Medicaid pricing and committed to $11 billion U.S. investment through 2029. It also announced a $300 million onshoring investment in New Jersey, enhancing its U.S. manufacturing footprint.
Aug 18, 2026 · 37 articles
Business
United States: The United States is the region where Roche and Nurix Therapeutics, Inc. will equally split profits and losses from the commercialization of bexobrutideg.
Jun 07, 2026 · 22 articles
Business
BeOne Medicines: BeOne Medicines received the 'Outstanding Global Oncology Company of the Year' award, recognizing its advancements in R&D and manufacturing of cancer therapies, which positively impacts its reputation and market standing.
May 11, 2026 · 6 articles
85
BeOne Medicines signed drug pricing deal United StatesTrump announces nine new...
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States and BeOne Medicines interact across events, view sentiment trends, and discover connected entities.
Open Dashboard